C22orf25 Antikörper (AA 25-75)

Produktnummer ABIN1386023

Der Kaninchen Polyklonal Anti-C22orf25-Antikörper wurde für WB, IF (p) und IHC (p) validiert. Er ist geeignet, C22orf25 in Proben von Human, Maus und Ratte zu detektieren.

Kurzübersicht für C22orf25 Antikörper (AA 25-75) (ABIN1386023)

Target: C22orf25 (Chromosome 22 Open Reading Frame 25 (C22orf25))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser C22orf25 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Produktdetails anti-C22orf25 Antikörper

Bindungsspezifität: AA 25-75

Kreuzreaktivität: Human, Maus, Ratte

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C22orf25

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400
IF(IHC-P) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Details zu C22orf25

Target: C22orf25 (Chromosome 22 Open Reading Frame 25 (C22orf25))

Andere Bezeichnung: C22orf25

Hintergrund:

Synonyms: Uncharacterized protein C22orf25, chromosome 22 open reading frame 25, DKFZp 761 P 1121, Hypothetical protein LOC128989, TNG2_HUMAN, TANGO2, Transport and Golgi organization protein 2 homolog.

Background: Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. The C22orf25 gene product has been provisionally designated C22orf25 pending further characterization.

Gen-ID: 128989

UniProt: Q6ICL3